Loading viewer...
investor_presentation
Format: PDF investor_presentation
Perrigo's February 2023 strategic offsite presentation outlining Phase 2 of its optimization and acceleration initiatives. The company addresses supply chain reinvention, recent acquisitions including HRA Pharma, and regulatory developments such as OTC oral contraceptive approvals, amid broader economic and geopolitical headwinds.
investor_presentation
17 Pages
Girls Leading Girls
Terran Orbital Corporation Investor Presentation 2022
investor_presentationinvestor_presentation
28 Pages
Terran Orbital Corporation
Balaxi Pharmaceuticals Investor Presentation
investor_presentationinvestor_presentation
21 Pages
Balaxi Pharmaceuticals Limited